首页> Med (New York, N.Y.)> The VIVID-1 study: A novel methodological approach provides further evidence of efficacy of selective IL-23 inhibition in Crohn's disease.

The VIVID-1 study: A novel methodological approach provides further evidence of efficacy of selective IL-23 inhibition in Crohn's disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Maria,Cappello

第一单位： Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Piazza delle Cliniche, 2, 90127 Palermo, Italy. Electronic address: marica.cappello61@gmail.com.

作者： Maria,Cappello ^[1] ; Ciro,Celsa ^[2]

作者单位： Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Piazza delle Cliniche, 2, 90127 Palermo, Italy. Electronic address: marica.cappello61@gmail.com. ^[1] Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Piazza delle Cliniche, 2, 90127 Palermo, Italy; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. ^[2]

医学主题词成年人(Adult);人类(Humans);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);Crohn病(Crohn Disease);白细胞介素23(Interleukin-23);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome)

DOI 10.1016/j.medj.2024.100572

PMID 39954670

发布时间 2025-05-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Med (New York, N.Y.)

2025年6卷2期

100572页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Med (New York, N.Y.)

2025年6卷2期

100572页

检索历史清除

The VIVID-1 study: A novel methodological approach provides further evidence of efficacy of selective IL-23 inhibition in Crohn's disease.

Med (New York, N.Y.)

相似文献

同项目论文

Med (New York, N.Y.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The VIVID-1 study: A novel methodological approach provides further evidence of efficacy of selective IL-23 inhibition in Crohn's disease.

Med (New York, N.Y.)

相似文献

同项目论文

Med (New York, N.Y.)

相关期刊

检索历史清除